Alasdair Johnson
Papers
1
Total Citations
152
H-Index
1
About
Alasdair Johnson is a leading figure in solid-state chemistry and pharmaceutical materials science, best known for pioneering high-throughput crystallization methodologies. His most impactful work, the 2002 paper "Iterative High-Throughput Polymorphism Studies on Acetaminophen and an Experimentally Derived Structure for Form III," has garnered 152 citations and introduced the groundbreaking CrystalMax platform. This integrated system—combining design software, robotic sample handling, and microanalytics—enabled the rapid screening of thousands of crystallization conditions, leading to the discovery and structural determination of acetaminophen Form III. Johnson's contributions have fundamentally transformed how researchers approach polymorph screening, accelerating the identification of stable drug forms critical for pharmaceutical development. His work bridges automation and fundamental crystallography, setting new standards for efficiency in materials characterization. With over 150 citations on this seminal paper alone, Johnson's influence extends across academic and industrial labs, where his methods are now standard practice for optimizing drug formulations and understanding solid-state diversity.
Research Focus
Key Achievements
Top Papers
- 1